143 related articles for article (PubMed ID: 36930561)
21. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
[TBL] [Abstract][Full Text] [Related]
22. Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus.
Yoshimi R; Ishigatsubo Y; Ozato K
Int J Rheumatol; 2012; 2012():718237. PubMed ID: 22701487
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis.
Martel ME; Leurs A; Launay D; Behal H; Chepy A; Collet A; Sanges S; Hachulla E; Dubucquoi S; Dauchet L; Sobanski V
Autoimmun Rev; 2024 May; 23(5):103536. PubMed ID: 38555075
[TBL] [Abstract][Full Text] [Related]
25. Isolated anti-Ro52 identifies a severe subset of Sjögren's syndrome patients.
Lee AYS; Putty T; Lin MW; Swaminathan S; Suan D; Chataway T; Thurlings RM; Gordon TP; Wang JJ; Reed JH
Front Immunol; 2023; 14():1115548. PubMed ID: 37006271
[TBL] [Abstract][Full Text] [Related]
26. Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.
Infantino M; Meacci F; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Ott A; Meyer W; Atzeni F; Sarzi-Puttini P; Manfredi M; Bizzaro N
Arthritis Res Ther; 2015 Dec; 17():365. PubMed ID: 26673754
[TBL] [Abstract][Full Text] [Related]
27. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
[TBL] [Abstract][Full Text] [Related]
28. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
29. Validation of an indirect ELISA assay for assessment of autoantibodies against full-length TRIM21 and its individual domains.
Dahl MLN; Mikkelsen JH; Hvid M; Korsholm TL; Nielsen KO; Andersen CBF; Greisen S; Deleuran B
Scand J Clin Lab Invest; 2023 Sep; 83(5):309-317. PubMed ID: 37379227
[TBL] [Abstract][Full Text] [Related]
30. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
31. Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients.
Lee A; Patterson KA; Tan DJ; Wilson ME; Proudman SM; Stevens W; Nikpour M; Sahhar J; Ngian GS; Roddy J; Roberts-Thomson PJ; Walker JG
Scand J Rheumatol; 2021 Nov; 50(6):469-474. PubMed ID: 33851896
[No Abstract] [Full Text] [Related]
32. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
33. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J
Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
[TBL] [Abstract][Full Text] [Related]
34. Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.
Espinosa A; Hennig J; Ambrosi A; Anandapadmanaban M; Abelius MS; Sheng Y; Nyberg F; Arrowsmith CH; Sunnerhagen M; Wahren-Herlenius M
J Biol Chem; 2011 Oct; 286(42):36478-91. PubMed ID: 21862588
[TBL] [Abstract][Full Text] [Related]
35. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
[TBL] [Abstract][Full Text] [Related]
39. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
[TBL] [Abstract][Full Text] [Related]
40. Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State.
Ruacho G; Kvarnström M; Zickert A; Oke V; Rönnelid J; Eketjäll S; Elvin K; Gunnarsson I; Svenungsson E
J Rheumatol; 2020 Jun; 47(6):865-875. PubMed ID: 31523050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
